tiprankstipranks
Trending News
More News >
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Ratios

Compare
397 Followers

Haemonetics Ratios

HAE's free cash flow for Q3 2025 was $0.56. For the 2025 fiscal year, HAE's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
2.56 3.06 1.71 2.74 2.12
Quick Ratio
1.50 2.03 1.05 1.46 1.17
Cash Ratio
0.60 1.13 0.59 0.76 0.48
Solvency Ratio
0.17 0.19 0.13 0.15 0.27
Operating Cash Flow Ratio
0.61 1.08 0.39 0.43 0.56
Short-Term Operating Cash Flow Coverage
17.77 23.17 0.80 6.39 2.06
Net Current Asset Value
$ -466.73M$ -347.11M$ -354.28M$ -394.71M$ -76.36M
Leverage Ratios
Debt-to-Assets Ratio
0.37 0.40 0.42 0.39 0.30
Debt-to-Equity Ratio
0.84 0.94 1.03 0.97 0.65
Debt-to-Capital Ratio
0.46 0.48 0.51 0.49 0.39
Long-Term Debt-to-Capital Ratio
0.45 0.48 0.43 0.49 0.34
Financial Leverage Ratio
2.29 2.37 2.48 2.49 2.16
Debt Service Coverage Ratio
9.95 8.46 0.68 4.40 2.72
Interest Coverage Ratio
12.67 10.67 4.72 3.44 9.50
Debt to Market Cap
0.19 0.18 0.24 0.12 0.07
Interest Debt Per Share
16.19 15.37 15.49 14.29 7.86
Net Debt to EBITDA
2.37 1.93 2.88 3.62 0.93
Profitability Margins
Gross Profit Margin
52.83%52.63%50.90%45.70%49.02%
EBIT Margin
12.60%13.35%8.13%10.31%10.46%
EBITDA Margin
20.29%21.34%17.97%16.34%26.73%
Operating Profit Margin
12.60%13.35%8.13%6.66%15.57%
Pretax Profit Margin
11.60%12.10%6.41%8.38%8.82%
Net Profit Margin
8.98%9.87%4.37%9.13%7.74%
Continuous Operations Profit Margin
8.98%9.87%4.37%9.13%7.74%
Net Income Per EBT
77.41%81.61%68.17%108.99%87.81%
EBT Per EBIT
92.10%90.62%78.80%125.79%56.61%
Return on Assets (ROA)
5.35%5.96%2.33%4.37%6.04%
Return on Equity (ROE)
12.25%14.11%5.79%10.86%13.03%
Return on Capital Employed (ROCE)
8.70%9.27%5.70%3.70%15.66%
Return on Invested Capital (ROIC)
6.70%7.51%3.36%3.97%12.67%
Return on Tangible Assets
9.60%9.67%4.01%8.04%8.29%
Earnings Yield
2.72%2.75%1.33%1.40%1.50%
Efficiency Ratios
Receivables Turnover
6.34 6.52 6.23 6.82 5.98
Payables Turnover
8.42 8.66 8.36 9.40 9.93
Inventory Turnover
1.95 2.13 1.66 1.46 1.86
Fixed Asset Turnover
3.57 3.76 3.84 4.00 3.90
Asset Turnover
0.60 0.60 0.53 0.48 0.78
Working Capital Turnover Ratio
2.65 2.81 2.64 2.29 3.00
Cash Conversion Cycle
201.73 184.82 234.19 263.79 220.01
Days of Sales Outstanding
57.60 55.95 58.57 53.49 61.00
Days of Inventory Outstanding
187.49 171.03 219.31 249.15 195.75
Days of Payables Outstanding
43.36 42.15 43.69 38.84 36.74
Operating Cycle
245.09 226.98 277.88 302.64 256.75
Cash Flow Ratios
Operating Cash Flow Per Share
3.58 5.38 3.37 2.15 3.12
Free Cash Flow Per Share
2.28 3.21 1.48 1.42 2.16
CapEx Per Share
1.31 2.17 1.89 0.73 0.96
Free Cash Flow to Operating Cash Flow
0.64 0.60 0.44 0.66 0.69
Dividend Paid and CapEx Coverage Ratio
2.74 2.48 1.78 2.94 3.24
Capital Expenditure Coverage Ratio
2.74 2.48 1.78 2.94 3.24
Operating Cash Flow Coverage Ratio
0.22 0.36 0.22 0.15 0.41
Operating Cash Flow to Sales Ratio
0.14 0.23 0.17 0.12 0.16
Free Cash Flow Yield
2.67%3.88%2.32%1.26%2.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
36.81 36.41 75.14 71.46 66.87
Price-to-Sales (P/S) Ratio
3.31 3.60 3.28 6.52 5.18
Price-to-Book (P/B) Ratio
4.51 5.14 4.35 7.76 8.72
Price-to-Free Cash Flow (P/FCF) Ratio
37.48 25.80 43.03 79.13 46.75
Price-to-Operating Cash Flow Ratio
23.81 15.39 18.92 52.20 32.34
Price-to-Earnings Growth (PEG) Ratio
16.71 0.22 -1.64 17.98 1.63
Price-to-Fair Value
4.51 5.14 4.35 7.76 8.72
Enterprise Value Multiple
18.66 18.78 21.14 43.55 20.29
EV to EBITDA
18.66 18.78 21.14 43.55 20.29
EV to Sales
3.79 4.01 3.80 7.12 5.43
EV to Free Cash Flow
42.93 28.76 49.81 86.31 48.99
EV to Operating Cash Flow
27.27 17.15 21.91 56.93 33.89
Tangible Book Value Per Share
-0.22 1.50 -0.55 -1.98 4.80
Shareholders’ Equity Per Share
18.93 16.11 14.68 14.43 11.58
Tax and Other Ratios
Effective Tax Rate
0.23 0.18 0.32 -0.09 0.12
Revenue Per Share
25.82 23.01 19.46 17.17 19.50
Net Income Per Share
2.32 2.27 0.85 1.57 1.51
Tax Burden
0.77 0.82 0.68 1.09 0.88
Interest Burden
0.92 0.91 0.79 0.81 0.84
Research & Development to Revenue
0.04 0.04 0.05 0.04 0.03
SG&A to Revenue
0.32 0.32 0.34 0.31 0.30
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.03 0.02
Income Quality
1.55 2.37 3.97 1.37 2.07
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis